-
-
Is It Hot In Here?; Homeopathy vs Conventional Medicine; FDA Actions
-
Researchers have identified 2 distinct strains of monkeypox virus, one of which appears to be significantly less virulent than the other, possibly explaining the lack of deaths in the 2003 Midwestern outbreak.
-
Mangia and colleagues in italy evaluated treatment of 283 patients with chronic hepatitis due to hepatitis C virus genotypes 2 and 3. They used a relatively select group of patients, and were able to follow them closely over the year of the study.
-
Neuraminidase inhibitors are a class of antivirals that have activity against both influenza A and B viruses. Influenza neuraminidase cleaves terminal sialic acid residues and damages the receptors recognized by viral hemagglutinin, thereby facilitating release of virus from infected cells.
-
Register now for the annual Contraceptive Technology: Quest for Excellence conference, scheduled for Oct. 27-29, 2005, in Atlanta.
-
The push is on to develop an effective male contraceptive, with almost $8 million from the National Institutes of Health (NIH) going to researchers at the University of Kansas in Lawrence and the University of Kansas Medical Center in Kansas City toward identifying potential chemical compounds for such use.
-
The 15-year-old young woman in your exam room tells you that she has crampy pelvic pain that begins shortly before or at the onset of her menstrual period that lasts one to three days. She says she usually misses a day of school each month due to the pain. What is your next move?
-
Investigators now are looking at a transcervical sterilization option that, if proven safe and effective, will give women another alternative for permanent contraception.
-
The next patient in your exam room is in her mid-20s. While she is in generally good health, you note she weighs in at 210 pounds. What contraceptive methods do you offer her?